Microvision saw the highest growth of 2.99% in patent filings in April and 2.66% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.99% and grants by 1.19%. GlobalData’s DataBook provides a comprehensive analysis of Microvision’s patent filings and grants. Buy the databook here.
Microvision has been focused on protecting inventions in Israel(IL) with eight publications in Q2 2024
The Israel(IL) Patent Office dominates the patent grants with nearly 28% of grants. The United States(US), European Patent Office(EPO), Israel(IL), and Canada(CA) patent Office are among the top ten patent offices where Microvision is filings its patents. Among the top granted patent authorities, Microvision has 28% of its grants in Israel(IL), 21% in Canada(CA) and 17% in China(CN).
Sony Group could be the strongest competitor for Microvision
Patents related to electronic warfare and autonomous vehicles lead Microvision's portfolio
Microvision has the highest number of patents in electronic warfare followed by, autonomous vehicles and industrial automation. For electronic warfare, nearly 71% of patents were filed and 64% of patents were granted in Q2 2024.
Automobile navigation systems related patents lead Microvision portfolio followed by intelligence, surveillance & reconnaissance, and autonomous sensor suite
Microvision has highest number of patents in automobile navigation systems followed by intelligence, surveillance & reconnaissance, autonomous sensor suite, interiors, and semiconductors. For automobile navigation systems, nearly 33% of patents were filed and 43% of patents were granted in Q2 2024.
For comprehensive analysis of Microvision's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.